Documents the rapid advances that have occurred in TB diagnosis, universal drug-susceptibility testing and treatment of dug-susceptible and drug-resistant TB, including multidrug-resistant and extensively drug-resistant TB, programmatic management of drug-resistant TB, public-private mix, the ENGAGE-TB approach, and END TB strategy, among others.
Prenumerera på vårt nyhetsbrev för att få fantastiska erbjudanden och inspiration för din nästa läsning.
Genom att registrera dig accepterar du vår personuppgiftspolicy.